Skip to main content
Premium Trial:

Request an Annual Quote

John Murphy, John Roush, Robert Friel, Eric Fung, Simon Shorter, Bjrn Ekstrm, Mor Amitai, Claire Fraser, and Steven Salzberg

Premium

John Murphy has been promoted to executive vice president and COO of PerkinElmer, a new position, the company said this week. Most recently, he was president of PE’s optoelectronics business. In this position, he was replaced by John Roush, who used to be vice president of product management and global sales and customer operations for optoelectronics.

Also, Robert Friel has been promoted to executive vice president for business development and CFO. He has been PE’s CFO since 1999.


Eric Fung has been promoted to vice president for clinical and medical affairs for the diagnostics division of Ciphergen Biosystems, the company said on this week. Simon Shorter has become vice president of business development.


Björn Ekström has become CEO of Olink Bioscience, a Swedish company focusing on protein analysis technology that was founded in September, Olink said last week. Previously, he was EVP and head of R&D at Pyrosequencing. He also held several positions within R&D at Amersham Biosciences and Pharmacia Biotech.


Mor Amitai will step down as president and CEO of Compugen by the end of 2005, the Tel Aviv-based company said on Sunday. Compugen is now searching for a new CEO with more experience in pharmaceutical product development and commercialization. Amitai, who has been heading Compugen for seven years, said he plans to “maintain an active role” in the company, albeit in a different capacity.


Claire Fraser and Steven Salzberg have become fellows of the American Association for the Advancement of Science, the Institute for Genome Research said last week. Fraser, who is president of TIGR, was honored for her efforts in the field of genomics, particularly in the sequencing and analysis of microbial genomes. Salzberg, TIGR’s senior bioinformatics director, was cited for new algorithms in bioinformatics, particularly for prokaryotic gene-finding algorithms, and for novel contributions to the analysis of multiple prokaryotic and eukaryotic genomes.

Filed under

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.